In this Shortcast with Pramod Sachdeva (Founder and Managing Director at Princeton Blue), we address the challenge of getting data from legacy systems into the context of the process thereby enhancing your current investments in Clinical and Regulatory systems. Listen to the audio below.
Pharma and biotech organizations rely on dozens of systems every day, including clinical, regulatory, lab, and others. But most of these systems were never designed to talk to each other. The result? Teams are still downloading data into spreadsheets, emailing files back and forth, and struggling to maintain visibility across global operations.
In this shortcast, Pramod Sachdeva explains how low-code Process Automation and data integration are changing that picture. He draws parallels to everyday innovations, showing how modern low-code platforms make it possible to connect siloed systems, streamline collaboration, and deliver new solutions far faster than ever possible before.
Pramod also reflects on what this shift means for life sciences organizations today—how companies can automate critical processes across clinical and regulatory and lab, to maximize the value of their existing technology investments and improve efficiency, transparency, and compliance across a variety of global drug development processes.
See how Merck Optimizes its Clinical Supply Chain
By Combining workflow automation and data integration across the clinical supply chain, Merck improves transparency, accountability, and the quality review and release process. (Co-presented by Merck, Princeton Blue and Appian at the SCOPE 2023 Conference.)
